Welcome Home Prozac Weight Gain Glutathione Antidepressants Benzodiazepines Other Medications Site Map
Click here for the Free E-book How to Get Off Psychoactive Drugs Safely
Review by Dr. Hyla Cass M.D. Psychiatrist "Here is an essential handbook on how to safely and more easily wean yourself (under medical supervision) off the heavily over-prescribed psychotropic medications. I have used the program with my patients and it works!” Hyla Cass M.D. Author of   Supplement Your Prescription The latest edition of How to  Get Off Psychotropic  Drugs Safely, is now  available as an e-book and  at Amazon.com. This  bestselling book details  what to do to avoid Prozac  withdrawal side effects,  what you can do to  eliminate existing Prozac  withdrawal side effects and  how to reduce the Prozac  safely. Click here for the  E-book which allows you  to receive the book  instantly! 
There is a Solution There is Hope
Physician’s Resource The physician’s psychoactive medication resource guide 25% of your patients taking an antidepressant will have weight gain and the weight gain is directly caused by the antidepressant.
LEXAPRO Lexapro side effects. Lexapro side effects, Lexapro side effect withdrawal solutions. Lexapro side effects. There is a way to eliminate Lexapro side effects without causing Lexapro withdrawal side effects. Lexapro side effects. Lexapro can be easy to taper off and side effects can be solved quickly, as long as you know what to do. The non-profit Public Charity, The Road Back Program offers the solutions for free and they will even guide you through what you need to do. Click here and you will be directed to The Road Back Program. Latest News SSRI Antidepressants May Up Stroke Risk After Menopause Date Published: Thursday, December 17th, 2009 Post-menopausal women taking selective serotonin reuptake inhibitor (SSRI) antidepressants have a small, though statistically higher risk of stroke, according to a newly published study. SSRIs include the drugs Prozac, Paxil, Zoloft, Lexapro, and Celexa. Antidepressant use in the US has more than quintupled since the early 1990s, and SSRIs have replaced older medications called tricyclic antidepressants, which can be toxic the heart. According to a press release announcing this latest study, SSRI antidepressants have fewer side effects in general and are known to have aspirin-like effects on bleeding, which could protect against clot-related cardiovascular disorders. But not much is known about how SSRIs affect the heart. This is especially true in the case of postmenopausal women, who are at increased risk for both heart disease and depression. The study, which was published in the December 14 Archives of Internal Medicine, involved 136,000 participants in the Women’s Health Initiative (WHI). None of the women were taking antidepressants when they enrolled in the WHI. The women included in the analysis had their first follow-up visit either one or three years after enrolling in WHI. At that time, 5,500 women reported taking either tricyclic or SSRI antidepressants. After six years, there was no association between antidepressant use and heart disease. However, researchers did find that women taking SSRIs had a 45 percent increase in risk of stroke and a 32 percent increase in risk of dying from any cause during follow up, compared with nonusers. Use of older tricyclic antidepressants wasn’t linked to stroke, but it did increase by 67 percent the risk of death during follow-up. The authors of the study said it wasn’t clear if the increased risk was the result of antidepressants or depression itself. Depression is a known risk factor for cardiovascular problems. There are a lot of things this study couldn’t tell us, such as whether this risk truly is attributable to the drugs and not to depression itself and whether participants were being treated for depression or for anxiety, which also has cardiovascular risks,” Jordan W. Smoller, MD, ScD, of the Massachusetts General Hospital (MGH) Department of Psychiatry, the study’s lead author, said in a press release. “We also don’t know whether there is any similar association in younger women or in men, since they were not part of this study.” The authors of the study called for more research into the relationship between antidepressants and death. Lexapro - Alert from the F.D.A. FDA ALERT [07/2005]: Suicidal Thoughts or Actions in Children and Adults Patients with depression or other mental illnesses often think about or attempt suicide.
Closely watch anyone taking antidepressants, especially early in treatment or when the dose is changed. Patients who become irritable or anxious, or have new or increased thoughts of suicide or other changes in mood or behavior (or their care givers) should contact their healthcare professional right away. Children Taking antidepressants may increase suicidal thoughts and actions in about 1 out of 50 people 18 years or younger. FDA has approved Zoloft for use in children only if they have obsessive-compulsive disorder. Adults Several recent scientific publications report the possibility of an increased risk for suicidal behavior in adults who are being treated with antidepressant medications. Even before these reports became available, FDA began a complete review of all available data to determine whether there is an increased risk of suicidal thinking or behavior in adults being treated with antidepressant medications. It is expected that this review will take a year or longer to complete. In the meantime, FDA is highlighting that adults being treated with antidepressant medication, particularly those being treated for depression, should be watched closely for worsening of depression and for increased suicidal thinking or behavior. This information reflects FDA’s preliminary analysis of data concerning this drug. FDA is considering, but has not reached a final conclusion about, this information. FDA intends to update this sheet when additional information or analyses become available.